Your browser doesn't support javascript.
loading
Protective effect of Qihuang Mingmu capsule on retina of diabetic mice and its impact on VEGF expression / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 3481-3485, 2012.
Artigo em Chinês | WPRIM | ID: wpr-308630
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the protective effect of Qihuang Mingmu capsule (QHMM) on retina of diabetic mice and its impact on VEGF expression.</p><p><b>METHOD</b>Forty KK/Upj-Ay mice were randomly divided into the model group and high, middle and low dose QHMM (8.32, 4.16, 2.08 g x kg(-1)) groups. Additional 10 C57BL/6 mice were selected as the control group. Mice were orally administered for three months. Their general appearance, fasting blood-glucose (FBG) and glycosylated hemoglobin (HbA1c) were observed. Pathological changes of retina were observed by light microscope and electron microscope. The expressions of vascular endothelial growth factor (VEGF), growth factor receptors-1 (Flt-1) and growth factor receptors-2 (Flk-1) were examined by Real-time PCR (qPCR) and Western blot.</p><p><b>RESULT</b>QHMM could ameliorate the symptoms of diabetic mice to varying degrees, decrease FBG and HbA1c, alleviate pathological lesions of retina and decrease the expressions of VEGF, Flt-1, Flk-1 mRNA and protein.</p><p><b>CONCLUSION</b>QHMM has the protective effect on diabetic retinopathy of mice by inhibiting the expressions of VEGF, Flt-1 and Flk-1 and intervening VEGF-VEGFR signal transduction pathway.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Doenças Retinianas / Cápsulas / Medicamentos de Ervas Chinesas / Expressão Gênica / Substâncias Protetoras / Fator A de Crescimento do Endotélio Vascular / Retinopatia Diabética / Tratamento Farmacológico / Genética / Metabolismo Tipo de estudo: Estudo prognóstico Limite: Animais / Humanos / Masculino Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2012 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Doenças Retinianas / Cápsulas / Medicamentos de Ervas Chinesas / Expressão Gênica / Substâncias Protetoras / Fator A de Crescimento do Endotélio Vascular / Retinopatia Diabética / Tratamento Farmacológico / Genética / Metabolismo Tipo de estudo: Estudo prognóstico Limite: Animais / Humanos / Masculino Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2012 Tipo de documento: Artigo